Hidehiro Itonaga Selected Research

Hidehiro Itonaga Research Topics

Disease

13	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2022 - 10/2014
12	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 05/2021 - 10/2011
9	Neoplasms (Cancer) 01/2022 - 03/2013
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2022 - 01/2017
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2021 - 04/2009
3	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 02/2016
3	Bronchiolitis Obliterans Syndrome 01/2019 - 01/2018
3	Leukemia 12/2018 - 03/2013
2	Lymphadenopathy 04/2019 - 01/2017
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2019 - 01/2017
2	Disease Progression 08/2018 - 10/2014
2	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2018 - 02/2016
1	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 05/2021
1	Pulmonary Alveolar Proteinosis 04/2020
1	Chromosome Aberrations (Chromosome Abnormalities) 02/2020
1	Thymoma (Thymic Carcinoma) 03/2019
1	Seizures (Absence Seizure) 01/2019
1	Erythema 01/2019
1	Hypoparathyroidism 01/2019
1	Lichen Planus (Lichen Ruber Planus) 01/2019
1	Multiple Myeloma 01/2019
1	Necrosis 01/2019
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2019
1	BCR-ABL Negative Atypical Chronic Myeloid Leukemia (Leukemia, Myeloid, Philadelphia Negative) 12/2018
1	Myasthenia Gravis 01/2018
1	Mucormycosis 01/2018
1	Splenomegaly 01/2017
1	Hodgkin Disease (Hodgkin's Disease) 01/2017
1	Pathologic Complete Response 02/2016
1	Primary Myelofibrosis (Myelosclerosis) 01/2016
1	Infections 04/2013

Drug/Important Bio-Agent (IBA)

3	Azacitidine (5 Azacytidine)FDA Link 12/2020 - 10/2014
3	LigandsIBA 12/2020 - 01/2016
2	fludarabineIBA 01/2022 - 12/2021
2	Busulfan (Busulfex)FDA Link 01/2022 - 12/2021
2	Tyrosine Kinase InhibitorsIBA 07/2021 - 01/2014
2	SteroidsIBA 01/2021 - 01/2018
2	mogamulizumabIBA 04/2020 - 11/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 10/2014
2	Imatinib Mesylate (Gleevec)FDA Link 02/2012 - 04/2009
1	NucleotidesIBA 01/2022
1	Pattern Recognition ReceptorsIBA 01/2022
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2021
1	AcetyltransferasesIBA 10/2021
1	Lenalidomide (CC 5013)FDA Link 04/2020
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 02/2020
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2019
1	ferric citrateIBA 01/2019
1	AntigensIBA 01/2019
1	CalciumIBA 01/2019
1	Peroxidase (Myeloperoxidase)IBA 01/2018
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2018
1	liposomal amphotericin B FDA Link 01/2018
1	Cholinergic ReceptorsIBA 01/2018
1	lipoarabinomannan (LAM)IBA 02/2016
1	Genetic Markers (Genetic Marker)IBA 01/2016
1	AntibodiesIBA 01/2016
1	MethyltransferasesIBA 10/2014
1	Decitabine FDA Link 10/2014
1	Phosphotransferases (Kinase)IBA 01/2014
1	PhosphoproteinsIBA 03/2013
1	Messenger RNA (mRNA)IBA 03/2013
1	Proto-Oncogene Proteins c-etsIBA 03/2013
1	NucleophosminIBA 03/2013
1	Transcription Factors (Transcription Factor)IBA 03/2013
1	Interferon-alpha (Interferon Alfa)IBA 02/2012

Therapy/Procedure

22	Hematopoietic Stem Cell Transplantation 10/2022 - 10/2011
7	Therapeutics 10/2022 - 11/2015
7	Transplantation 10/2020 - 04/2013
4	Drug Therapy (Chemotherapy) 04/2019 - 01/2017
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2019 - 01/2019
2	Salvage Therapy 08/2018 - 12/2013
2	Radiotherapy 01/2018 - 01/2017
2	Stem Cell Transplantation 01/2018 - 01/2017
1	Immunotherapy 01/2022
1	Thymectomy 03/2019
1	Thyroidectomy 01/2019
1	Homologous Transplantation 01/2019
1	Parathyroidectomy 01/2019
1	Plasmapheresis 01/2018
1	Debridement 01/2018
1	Cell Transplantation 02/2015